viernes, 21 de agosto de 2026

Regeneron drug for disease that causes dangerous bone growth earns FDA approval The medicine drastically cut the risk of new bone formation in a pivotal trial

https://www.statnews.com/2026/08/19/regeneron-fop-garetosmab-fda-approval-pasatru/ by Andrew JosephAug. 19, 2026 Europe Correspondent

No hay comentarios: